| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | leptomycin B | CTRPv2 | pan-cancer | AAC | -0.22 | 4e-11 |
| mRNA | dinaciclib | CTRPv2 | pan-cancer | AAC | -0.3 | 4e-10 |
| mRNA | alvocidib | CTRPv2 | pan-cancer | AAC | -0.29 | 2e-09 |
| mRNA | carboplatin:UNC0638 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.19 | 2e-07 |
| mRNA | MLN2238 | CTRPv2 | pan-cancer | AAC | -0.17 | 4e-07 |
| mRNA | BCL-LZH-4 | CTRPv2 | pan-cancer | AAC | 0.26 | 1e-06 |
| mRNA | Methotrexate | CTRPv2 | pan-cancer | AAC | -0.18 | 2e-06 |
| mRNA | BRD-K20514654 | CTRPv2 | pan-cancer | AAC | 0.25 | 4e-06 |
| mRNA | GDC-0879 | CTRPv2 | pan-cancer | AAC | -0.16 | 4e-06 |
| mRNA | BRD-K48477130 | CTRPv2 | pan-cancer | AAC | 0.26 | 5e-06 |